According to the research report titled ‘Global Non-steroidal Anti-inflammatory Drugs Market Size study, by Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, Others) by Route of Administration (Oral, Topical, Others) by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)and Regional Forecasts 2022-2028’ available with MarketStudyReport, global nonsteroidal anti-inflammatory drugs (NSAIDs) market is expected to amass sustainable returns during 2022-2028.

Expansion of global non-steroidal anti-inflammatory drugs (NSAIDs) market is accelerating due to factors like rising prevalence of chronic pain and rapid increase in the old-age population across the world.

Ask for discount on this report: https://www.marketstudyreport.com/request-a-sample/5490059/   

Additionally, market growth is anticipated to be driven by expanding over-the-counter (OTC) NSAID demand as well as increased use of the product for migraine, headaches, toothaches, and menstruation pain.

Notably, with the uptick in the senior population, chronic pain has become more prevalent, with soaring number of patients suffering from CVDs, cancer, diabetes, chronic pain, arthritis, and other diseases. As a result, the progress of the business sphere is estimated to be fueled by the increased prevalence of ailments like arthritis and other pain-related illnesses during the course of the forecast period.  

However, the ill effects of the drugs might hamper worldwide non-steroidal anti-inflammatory drugs market expansion throughout the projection period of 2022-2028.

This business space is segmented in terms of route of administration, disease indication, and distribution channel. On the basis of route of administration, the market is split into topical, oral, and other routes.

In terms of disease indication, this marketplace is divided into migraine, arthritis, ophthalmic diseases, and others. Among these, arthritis segment is estimated to exhibit a modest growth rate during the analysis period, owing to the increasing older population.

Based on the distribution channel, the market is bifurcated into retail pharmacy, online pharmacy, and hospital pharmacy.

Speaking of geographical outlook, the industry vertical spans across Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Of these, Asia Pacific market stands tall in terms of revenue potential over the analysis period, due to increasing prevalence of chronic pain, migraines, & headaches, growing aging population, and rising proportion of product approvals & launches in the region.

Whereas North America industry is estimated to exhibit a significant growth rate during the analysis period, due to the presence of leading players taking impactful efforts & initiatives as well as an increase in arthritis disease detection in the region.

In terms of competitive landscape, global non-steroidal anti-inflammatory drugs marketplace consists of major companies such as Becton Dickinson & Company, Merck & Co., Inc., Johnson And Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Dr. Reddy's Laboratories Ltd., GSK plc, Bayer AG, Bioject Medical Technologies Inc. and Pfizer Inc.